252 related articles for article (PubMed ID: 18850577)
1. Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment.
Arnold RS; Sun CQ; Richards JC; Grigoriev G; Coleman IM; Nelson PS; Hsieh CL; Lee JK; Xu Z; Rogatko A; Osunkoya AO; Zayzafoon M; Chung L; Petros JA
Prostate; 2009 Jan; 69(1):1-11. PubMed ID: 18850577
[TBL] [Abstract][Full Text] [Related]
2. Bone metastasis in prostate cancer: Recurring mitochondrial DNA mutation reveals selective pressure exerted by the bone microenvironment.
Arnold RS; Fedewa SA; Goodman M; Osunkoya AO; Kissick HT; Morrissey C; True LD; Petros JA
Bone; 2015 Sep; 78():81-6. PubMed ID: 25952970
[TBL] [Abstract][Full Text] [Related]
3. mtDNA mutations increase tumorigenicity in prostate cancer.
Petros JA; Baumann AK; Ruiz-Pesini E; Amin MB; Sun CQ; Hall J; Lim S; Issa MM; Flanders WD; Hosseini SH; Marshall FF; Wallace DC
Proc Natl Acad Sci U S A; 2005 Jan; 102(3):719-24. PubMed ID: 15647368
[TBL] [Abstract][Full Text] [Related]
4. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of CRMP4, a new prostate cancer metastasis suppressor gene, inhibits tumor growth in a nude mouse intratibial injection model.
Zhou W; Xie P; Pang M; Yang B; Fang Y; Shu T; Liu C; Wang X; Zhang L; Li S; Rong L
Int J Oncol; 2015 Jan; 46(1):290-8. PubMed ID: 25338524
[TBL] [Abstract][Full Text] [Related]
6. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
7. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ
Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751
[TBL] [Abstract][Full Text] [Related]
8. Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis.
Shidara Y; Yamagata K; Kanamori T; Nakano K; Kwong JQ; Manfredi G; Oda H; Ohta S
Cancer Res; 2005 Mar; 65(5):1655-63. PubMed ID: 15753359
[TBL] [Abstract][Full Text] [Related]
9. Targeting ECM-integrin interaction with liposome-encapsulated small interfering RNAs inhibits the growth of human prostate cancer in a bone xenograft imaging model.
Bisanz K; Yu J; Edlund M; Spohn B; Hung MC; Chung LW; Hsieh CL
Mol Ther; 2005 Oct; 12(4):634-43. PubMed ID: 16039164
[TBL] [Abstract][Full Text] [Related]
10. RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes.
Armstrong AP; Miller RE; Jones JC; Zhang J; Keller ET; Dougall WC
Prostate; 2008 Jan; 68(1):92-104. PubMed ID: 18008334
[TBL] [Abstract][Full Text] [Related]
11. Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein.
Li Y; Che M; Bhagat S; Ellis KL; Kucuk O; Doerge DR; Abrams J; Cher ML; Sarkar FH
Neoplasia; 2004; 6(4):354-63. PubMed ID: 15256057
[TBL] [Abstract][Full Text] [Related]
12. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
Hsieh CL; Gardner TA; Miao L; Balian G; Chung LW
Cancer Gene Ther; 2004 Feb; 11(2):148-55. PubMed ID: 14695756
[TBL] [Abstract][Full Text] [Related]
13. A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis.
Matsubara S; Wada Y; Gardner TA; Egawa M; Park MS; Hsieh CL; Zhau HE; Kao C; Kamidono S; Gillenwater JY; Chung LW
Cancer Res; 2001 Aug; 61(16):6012-9. PubMed ID: 11507044
[TBL] [Abstract][Full Text] [Related]
14. A mitochondrial DNA mutation influences the apoptotic effect of statins on prostate cancer.
Sun Q; Arnold RS; Sun CQ; Petros JA
Prostate; 2015 Dec; 75(16):1916-25. PubMed ID: 26383260
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
[TBL] [Abstract][Full Text] [Related]
16. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR
Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910
[TBL] [Abstract][Full Text] [Related]
17. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
[TBL] [Abstract][Full Text] [Related]
18. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
[TBL] [Abstract][Full Text] [Related]
19. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model.
Tuxhorn JA; McAlhany SJ; Dang TD; Ayala GE; Rowley DR
Cancer Res; 2002 Jun; 62(11):3298-307. PubMed ID: 12036948
[TBL] [Abstract][Full Text] [Related]
20. Identification of a unique set of genes altered during cell-cell contact in an in vitro model of prostate cancer bone metastasis.
Wang J; Levenson AS; Satcher RL
Int J Mol Med; 2006 May; 17(5):849-56. PubMed ID: 16596270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
